𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preliminary results of a phase I/II study With Pi-Meson (Pion) treatment for bladder cancer

✍ Scribed by Urs E. Studer; Carl F. Von Essen; Jean-Bernard Enderli; Gerd Bodendörfer; Ernst J. Zingg

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
850 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CMF + radiotherapy in the primary treatm
CMF + radiotherapy in the primary treatment of operable breast cancer: Preliminary results of a phase II pilot study
✍ Bellantone, Rocco; Lombardi, Celestino Pio; Cefaro, Giampiero Ausili; Nardone, L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

Background and Objectives: Chemotherapy and radiotherapy have been investigated in several studies about their role in primary (neoadjuvant) treatment before surgery in breast cancer. We proposed a pilot study to evaluate a primary scheme of alternate radio-chemotherapy in the treatment of operable

Ex vivo ras peptide vaccination in patie
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study
✍ Marianne K. Gjertsen; Arne Bakka; Jarle Breivik; Ingvil Saeterdal; Tobias Gedde- 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 434 KB 👁 2 views

In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding

A supportive–expressive group interventi
A supportive–expressive group intervention for women with a family history of breast cancer: results of a phase II study
✍ Mary Jane Esplen; Brenda Toner; Jonathan Hunter; Gordon Glendon; Alexander Liede 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Background: Evidence suggests that there are significant psychological and behavioural sequelae associated with having a family history of breast cancer (BC) which can interfere with comprehension of risk estimates. Purpose: The purpose of this study was to develop, standardize and do preliminary t

Treatment of refractory acute myeloid le
Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study
✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas Büc 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru

Increased toxicity and lack of efficacy
Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study
✍ Carlos R. Becerra; Eugene P. Frenkel; Raheela Ashfaq; Richard B. Gaynor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 1 views

## Abstract Preclinical and clinical models have demonstrated that cyclooxygenase‐2 (COX‐2) is overexpressed in primary and metastatic colorectal tumors. In preclinical models, there appears to be additive or synergistic effects when combining 5‐Fluorouracil (5‐FU) with nonsteroidal anti‐inflammato